Drug Antitrust Issues With Daraprim And Beyond
The pharmaceutical industry presents some of the most important issues in U.S. antitrust law today. This article focuses on three examples: settlements between brand and generic companies, "product hopping" from one...To view the full article, register now.
Already a subscriber? Click here to view full article